Expertise in Enhancing Revenue, Efficiency, Operations and Compliance for Healthcare Systems
40 Years
Proven track record in revenue cycle management
1100 +
Hospital Facilities and Physician Groups Nationwide
540
Credentialed Consultants & Staff
96% +
Coding accuracy based on 3rd party audits
Top 3 Best in KLAS for outsourced coding for past 8 years
UASI is Trusted by 1100+ Hospital Facilities and Physician Groups Nationwide
Our Solutions
Mid-Rev Cycle Solutions that Work
Program Design, Implementation and Optimization
Our pragmatic approach targets specific opportunities to enhance standards, fiscal objectives, and regulatory compliance, thereby boosting performance and fortifying outcomes.
Assessments and
Audits
Achieve higher quality outcomes and an attainable ROI with ongoing and strategic audits and reviews of your operation.
Education and Training
We facilitate the shift to value-based care with expert support in people, processes, and technology, offering a measured approach for quick ROI and scalable success.
Staffing and Managed Services
Achieve coding, CDI, or revenue integrity staffing flexibility with confidence, surpassing accuracy, quality, and productivity goals through our tiered support model.
Our Services
Discover a comprehensive range of healthcare solutions designed to optimize revenue, enhance compliance, and improve operational efficiency. From coding and CDI to risk-based services and revenue integrity, UASI provides expert support to meet your unique needs.
CODING SERVICES
Achieve accurate, compliant, and efficient coding with our professional coding services, supporting inpatient, outpatient, and specialty coding needs with UASI.
RISK BASED SERVICES
At UASI, we optimize your risk adjustment and value-based care initiatives with our specialized risk-based services, ensuring accurate coding and improved financial outcomes.
CDI SERVICES
UASI enhances the accuracy and completeness of your clinical documentation, ensuring compliance and optimal reimbursement through our expert CDI services.
DENIALS & REVENUE INTEGRITY
Maintain financial health and compliance with UASI's comprehensive revenue integrity services, including auditing, denials management, and process optimization.
“I have worked with UASI for many years, they are my go to for CDI. UASI provides experienced CDI staffing resources as well great products with their CDI assessment and their customizable CDI audits. Partnering with UASI is helping our CDI team continuously grow and improve.”
- Tallahassee Memorial Healthcare
Education
Explore UASI's comprehensive resource page for valuable insights, tools, and expertise in healthcare staffing, revenue cycle management, and compliance solutions
Transient Tachypnea of the Newborn (TTN) TTN : a parenchymal lung disorder characterized by pulmonary edema resulting from delayed resorption and clearance of fetal alveolar fluid. It is the most common cause of respiratory distress in late preterm and term infants and is generally a benign, self-limited condition. Clinical Manifestations of TTN · Onset usually between the time of birth and two hours after delivery · Tachypnea – most common feature with respiratory rate > 60 breaths per minute · Infants with more severe disease may exhibit: Cyanosis Increased work of breathing which includes: Nasal flaring Mild intercostal and subcostal retractions Expiratory grunting · Anterior-posterior diameter of the chest may be increased · Typically with clear lungs (no rales/rhonchi) · Mild to moderate TTN are symptomatic for 12-24 hours but signs may persist as long as 72 hours in more severe cases · Characteristic radiographic features: o CXR – increased lung volumes with flat diaphragms, mild cardiomegaly, prominent vascular markings in a sunburst pattern originating at the hilum, fluid in the interlobar fissures, pleural effusions, alveolar edema appearing as fluffy densities. There are no areas of alveolar densities or consolidation o Lung US – pulmonary edema, compact B lines, double lung point, regular pleural line without consolidation TTN is a benign disorder and pathologic conditions that also present with respiratory distress must be excluded. Pneumonia – chest radiography differentiates PNA from TTN as neonatal PNA is characterized by alveolar densities with air bronchograms or patchy infiltrates, not seen in TTN. Sepsis – infants with sepsis and respiratory distress are differentiated from those with TTN with the persistence of additional symptoms and the lack of the characteristic chest radiographic findings of TTN. Congenital cardiac disease - TTN is distinguished from congenital heart disease by physical findings (e.g., heart murmur, abnormal precordial activity), chest radiography, pre- and post-ductal pulse oximetry, and echocardiography. Respiratory distress syndrome – differentiated from TTN with a characteristic chest radiograph of a ground glass appearance with air bronchograms. Caused by surfactant deficiency most common in very preterm infants. Code for Transient tachypnea of newborn (TTN) falls under ICD-10 Chapter 16 – Certain conditions originating in the perinatal period [P00-P96] · P19-P29 – Respiratory and cardiovascular disorders specific to the perinatal period · P22 - Respiratory distress of newborn · P22.0 – Respiratory distress syndrome of newborn · P22.1 – Transient tachypnea of newborn · P22.8 – Other respiratory distress of newborn · P22.9 – Respiratory distress of newborn, unspecified Additional Tips: · TTN is also documented as Respiratory distress syndrome Type II, Wet lung syndrome · Tachypnea alone is just a symptom · Most common risk factors for TTN include prematurity, Cesarean delivery, maternal diabetes, maternal obesity, maternal asthma · Infants with TTN rarely require a fraction of inspired oxygen (FiO2) >0.4. References Johnson, K. E. (2021, August 30). Transient tachypnea of the newborn. UpToDate. www.uptodate.com/contents/transient-tachypnea-of-the-newborn “Respiratory Conditions Neonatal.” Pro ACDIS Pocket Resource Online, pro.acdis.org/inpatient/conditions/respiratory-conditions-neonatal. Accessed 4 Dec. 2023.
Can Providers Truly Win?
This is a short synopsis of a possible patient record and is not intended to be all-inclusive. This is for educational purposes only and not intended to replace your institutional guidelines.
Insights
Explore our INSIGHTS section for valuable resources, including articles, results, whitepapers, case studies, and more. Stay informed and gain expert knowledge to drive your healthcare organization's success with UASI.
Can Providers Truly Win?
Cincinnati, OH — UASI is excited to announce the addition of Rachel Mack, MSN, RN, CCDS, CDIP, CCS, CRC, to the team as Managing Consultant in Clinical Documentation Integrity (CDI). Rachel brings over 15 years of experience in CDI and healthcare management, with a well-rounded background as a CDI Specialist, Educator, and Auditor. Her expertise in inpatient hospital CDI/coding, CDI technology, risk adjustment methodologies, and Medicare will significantly enhance UASI's commitment to delivering exceptional documentation solutions. Rachel has demonstrated her dedication to advancing CDI through her strong leadership in program and project management, with a Master's degree in Nursing Administration from Jacksonville University. She has worked closely with physicians to implement effective CDI strategies and has a proven track record in PSI prevention and Medicare compliance. “I am passionate about all things CDI and am thrilled to bring my experience to UASI,” said Rachel Mack. “I look forward to working with a team that shares my commitment to enhancing healthcare outcomes through innovative CDI practices.” Rachel's industry influence extends beyond her work with hospitals. She has been a sought-after speaker at major industry conferences, including her recent presentation on Social Determinants of Health (SDoH) at the 2023 ACDIS Conference alongside Connie Ryan. She also organized and presented at Vizient’s webinar series in 2021, 2022, and 2023, covering topics like CDI and Cardiac Surgery, Sepsis, Respiratory Failure, Risk Adjustment, and PSIs/HACs. Rachel's expertise and thought leadership were also featured at several ACDIS Conferences. About UASI For over four decades, UASI Solutions has led the healthcare industry in revenue cycle management, providing tailored solutions to optimize fiscal performance and drive sustainable growth. Established in 1984, our commitment to innovation and client success has solidified our position as trusted partners nationwide. With a comprehensive suite of services, including Remote Coding, Clinical Documentation Improvement, and Revenue Integrity, we remain dedicated to delivering value and driving results for our clients every step of the way. For more information, please visit www.uasisolutions.com .
Cincinnati, OH — UASI is proud to welcome Lou Ann Wiedemann, MS, FAHIMA, RHIA, CDIP, CHDA, as Managing Consultant in Coding and Auditing. Lou Ann brings over 22 years of leadership experience in health information management, association management, and strategic planning. Her expertise in business and content development, coupled with her passion for data-driven decisions, mentoring young professionals, and fostering collaboration, will strengthen UASI’s position as a leader in revenue cycle management. Lou Ann’s dedication to the health information profession is evident through her impressive credentials, including a Master's of Science in Health Information Management, and recognition as a Fellow of AHIMA. In addition to her coding and CDI expertise, she brings a wealth of experience in data analytics, healthcare consulting, HIPAA, healthcare information technology (HIT), and revenue cycle management. Her hands-on knowledge of Electronic Health Records (EHRs) further enhances her ability to deliver innovative solutions for UASI’s clients. "Lou Ann’s exceptional experience and commitment to lifelong learning align perfectly with UASI’s mission of providing outstanding healthcare solutions," said Nancy Koors, CEO of UASI. "Her leadership will undoubtedly drive our coding and auditing services to new heights, and we are thrilled to have her as part of the team." Lou Ann is also a seasoned speaker, author, and faculty member with a strong presence in the hospital and healthcare industry, making her a thought leader in the field. Her ability to guide teams through complex challenges and her focus on continuous improvement make her a valuable addition to UASI’s team. About UASI For over four decades, UASI Solutions has led the healthcare industry in revenue cycle management, providing tailored solutions to optimize fiscal performance and drive sustainable growth. Established in 1984, our commitment to innovation and client success has solidified our position as trusted partners nationwide. With a comprehensive suite of services, including Remote Coding, Clinical Documentation Improvement, and Revenue Integrity, we remain dedicated to delivering value and driving results for our clients every step of the way. For more information, please visit www.uasisolutions.com .
Coding Tips
Stay ahead with UASI Coding Tips section, featuring practical advice, industry updates, and best practices to enhance your coding accuracy and efficiency.
Transient Tachypnea of the Newborn (TTN) TTN : a parenchymal lung disorder characterized by pulmonary edema resulting from delayed resorption and clearance of fetal alveolar fluid. It is the most common cause of respiratory distress in late preterm and term infants and is generally a benign, self-limited condition. Clinical Manifestations of TTN · Onset usually between the time of birth and two hours after delivery · Tachypnea – most common feature with respiratory rate > 60 breaths per minute · Infants with more severe disease may exhibit: Cyanosis Increased work of breathing which includes: Nasal flaring Mild intercostal and subcostal retractions Expiratory grunting · Anterior-posterior diameter of the chest may be increased · Typically with clear lungs (no rales/rhonchi) · Mild to moderate TTN are symptomatic for 12-24 hours but signs may persist as long as 72 hours in more severe cases · Characteristic radiographic features: o CXR – increased lung volumes with flat diaphragms, mild cardiomegaly, prominent vascular markings in a sunburst pattern originating at the hilum, fluid in the interlobar fissures, pleural effusions, alveolar edema appearing as fluffy densities. There are no areas of alveolar densities or consolidation o Lung US – pulmonary edema, compact B lines, double lung point, regular pleural line without consolidation TTN is a benign disorder and pathologic conditions that also present with respiratory distress must be excluded. Pneumonia – chest radiography differentiates PNA from TTN as neonatal PNA is characterized by alveolar densities with air bronchograms or patchy infiltrates, not seen in TTN. Sepsis – infants with sepsis and respiratory distress are differentiated from those with TTN with the persistence of additional symptoms and the lack of the characteristic chest radiographic findings of TTN. Congenital cardiac disease - TTN is distinguished from congenital heart disease by physical findings (e.g., heart murmur, abnormal precordial activity), chest radiography, pre- and post-ductal pulse oximetry, and echocardiography. Respiratory distress syndrome – differentiated from TTN with a characteristic chest radiograph of a ground glass appearance with air bronchograms. Caused by surfactant deficiency most common in very preterm infants. Code for Transient tachypnea of newborn (TTN) falls under ICD-10 Chapter 16 – Certain conditions originating in the perinatal period [P00-P96] · P19-P29 – Respiratory and cardiovascular disorders specific to the perinatal period · P22 - Respiratory distress of newborn · P22.0 – Respiratory distress syndrome of newborn · P22.1 – Transient tachypnea of newborn · P22.8 – Other respiratory distress of newborn · P22.9 – Respiratory distress of newborn, unspecified Additional Tips: · TTN is also documented as Respiratory distress syndrome Type II, Wet lung syndrome · Tachypnea alone is just a symptom · Most common risk factors for TTN include prematurity, Cesarean delivery, maternal diabetes, maternal obesity, maternal asthma · Infants with TTN rarely require a fraction of inspired oxygen (FiO2) >0.4. References Johnson, K. E. (2021, August 30). Transient tachypnea of the newborn. UpToDate. www.uptodate.com/contents/transient-tachypnea-of-the-newborn “Respiratory Conditions Neonatal.” Pro ACDIS Pocket Resource Online, pro.acdis.org/inpatient/conditions/respiratory-conditions-neonatal. Accessed 4 Dec. 2023.
Can Providers Truly Win?
Diabetes Mellitus: is impaired insulin secretion and variable degrees of peripheral insulin resistance leading to hyperglycemia. The 2 main categories of diabetes mellitus are: Type 1 - The body’s immune system destroys the beta cells within the pancreas, leading to an inability to produce insulin. Type 1 diabetes requires daily insulin therapy. Historically described as juvenile-onset diabetes. Accounts for less than 10% of all cases of diabetes mellitus. Type 2 - The body still produces insulin, but the body’s cells are unable to utilize the insulin efficiently, leading to insulin resistance. Liver and fat cells are inefficient at absorbing the insulin, resulting in higher glucose levels and increased insulin production. The pancreas loses the ability to produce adequate levels of insulin. May require insulin replacement. Hyperglycemia : Blood sugar > 140 mg/dL Provider documentation should clearly identify diabetes complications as “hypoglycemia” or “hyperglycemia” instead of “uncontrolled diabetes” to ensure accurate code assignment. Example: A patient with a history of type 2 diabetes was found to have blood sugars ranging from 150-220 mg/dL. The provider documents “uncontrolled diabetes” in the H&P. A query should be sent to clarify the diagnosis as “Diabetes mellitus type 2 with hyperglycemia” for accurate capture of the diagnosis. Diabetes mellitus type 2 with hyperglycemia is an Elixhauser variable and an HCC. Provider documentation should clearly differentiate POA status of DM with hyperglycemia when related complications are also documented, such as HHS or DKA. Example: When a provider documents hyperglycemia as POA and a second provider later determines the patient has DKA or HHS. CDI should send a query for clarification of the POA status of documented conditions. CDI would also send a clinical validation query if HHS or DKA is lacking sufficient clinical evidence to support the diagnosis. Provider documentation should clarify if “diabetes type 2 with hyperglycemia” is a complication of a medical treatment to capture appropriate code assignment. Example: A patient with pre-existing type 2 diabetes mellitus presented with hyperglycemia, and the provider notes hyperglycemia is likely secondary to autoimmune DM, which occurred following immunotherapy initiation. Assign codes for Diabetes type 2 with hyperglycemia, and an additional code for the adverse effect of antineoplastic and immunosuppressive drugs. If there is any question of a cause-and-effect relationship, a query would be warranted for clarification. In the OP arena, look for an A1c > 7 to consider a query for control status, unless the provider documents a specific goal in the visit note i.e. A1c goal is < 7.5, etc. NCQA / HEDIS Comprehensive Diabetes Care measure looks for HbA1c control (<8.0%). See below:
Bridging Financial, Clinical and Operations for Optimal Outcomes
Are you ready
to take the next steps?
Apply now and let's see if it's a good fit!
UASI is an Equal Opportunity/Affirmative Action Employer
